{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:04:10Z","timestamp":1791054250754,"version":"4.1.0"},"reference-count":115,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>Intellectual disability is common and is associated with significant morbidity. Until the latter half of the 20th century, there were no efficacious treatments. Following initial breakthroughs associated with newborn screening and metabolic corrections, little progress was made until recently. With improved understanding of genetic and cellular mechanisms, novel treatment options are beginning to appear for a number of specific conditions. Fragile X and tuberous sclerosis offer paradigms for the development of targeted therapeutics, but advances in understanding of other disorders such as Down syndrome and Rett syndrome, for example, are also resulting in promising treatment directions. In addition, better understanding of the underlying neurobiology is leading to novel developments in enzyme replacement for storage disorders and adjunctive therapies for metabolic disorders, as well as potentially more generalizable approaches that target dysfunctional cell regulation via RNA and chromatin. Physiologic therapies, including deep brain stimulation and transcranial magnetic stimulation, offer yet another direction to enhance cognitive functioning. Current options and evolving opportunities for the intellectually disabled are reviewed and exemplified. Ann Neurol 2013;74:382\u2013390<\/jats:p>","DOI":"10.1002\/ana.24002","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T17:27:07Z","timestamp":1376674027000},"page":"382-390","source":"Crossref","is-referenced-by-count":33,"title":["New innovations: Therapeutic opportunities for intellectual disabilities"],"prefix":"10.1002","volume":"74","author":[{"given":"Jonathan D.","family":"Picker","sequence":"first","affiliation":[{"name":"Division of Genetics Boston Children's Hospital, and Howard Hughes Medical Institute Boston MA"},{"name":"Departments of Pediatrics and Neurology, Harvard Medical School Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Division of Genetics Boston Children's Hospital, and Howard Hughes Medical Institute Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"e_1_2_10_2_1","volume-title":"A history of mental retardation","author":"Scheerenberger RC","year":"1983"},{"key":"e_1_2_10_3_1","article-title":"Stigma, public awareness about intellectual disability and attitudes to inclusion among different ethnic groups","author":"Scior K","journal-title":"J Intellect Disabil Res"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2012.12.017"},{"key":"e_1_2_10_5_1","unstructured":"BraddockD.BraddockD.Public spending for disability in the United States: 1997\u20132006. Boston: Federal Reserve Bank of Boston. Paper presented at: Conference on Housing for People with Disabilities; February 4\u20135 2010; Washington DC."},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042711-140053"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.2051-5545.2011.tb00045.x"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neunet.2012.09.017"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.04.024"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2012.07.007"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-010-0176-5"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2002.1255"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2012.02.002"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1209236"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2011.01.002"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1667"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2004.04.009"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.10.5401"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4650-11.2012"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00687814"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/279834"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035885"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2010.191072"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.066852"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.193458.112"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.652"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/10799893.2013.779279"},{"key":"e_1_2_10_28_1","article-title":"Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature","author":"Bena F","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32036"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.3104\/perspectives.311"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/0300443961180108"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(53)90473-5"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0257"},{"key":"e_1_2_10_34_1","first-page":"8","article-title":"Newborn screening for congenital hypothyroidism","volume":"5","author":"Buyukgebiz A","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/09297040701864570"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-44"},{"key":"e_1_2_10_37_1","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis\u2010I from newborn blood spots by tandem mass spectrometry","author":"Scott CR","journal-title":"Journal of Pediatrics"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/08830738050200082901"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0693"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.07.052"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182553c11"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31323"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-1191-12"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181a27a16"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9394-5"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0011-x"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61234-3"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012754724708"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11860"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004214"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.063701"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e318287cd17"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/124548"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5327.805"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb839"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202476899"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2295"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2109"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4698-08.2008"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2008.09.022"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/aur.132"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/486402"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/13810"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2006.04.009"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1139\/O10-112"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3077-12.2012"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610593104"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1138389"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.12.027"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/679801"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00256.x"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199901180-00031"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-6-19"},{"key":"e_1_2_10_75_1","first-page":"CD002854","article-title":"Vitamin E for Alzheimer's dementia and mild cognitive impairment","volume":"11","author":"Farina N","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-120349"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.66"},{"key":"e_1_2_10_78_1","doi-asserted-by":"crossref","first-page":"171639","DOI":"10.1155\/2012\/171639","article-title":"Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics","volume":"2012","author":"Creau N","year":"2012","journal-title":"Neural Plast"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-54299-1.00001-7"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64650"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/101542"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.10.009"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.29.051605.112839"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.4161\/cib.2.5.8834"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.01.005"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn011"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.02.016"},{"key":"e_1_2_10_88_1","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","author":"Darnell JC","journal-title":"Nat Neurosci"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.033407"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2013.02.012"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23638"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051253"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23543"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2011.633508"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2011.588204"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.2.98"},{"key":"e_1_2_10_97_1","first-page":"616310","article-title":"Development of safer gene delivery systems to minimize the risk of insertional mutagenesis\u2010related malignancies: a critical issue for the field of gene therapy","volume":"2012","author":"Romano G","year":"2012","journal-title":"ISRN Oncol"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2004.06.002"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402229200"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-011112-140216"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2004.05.021"},{"key":"e_1_2_10_102_1","doi-asserted-by":"publisher","DOI":"10.1101\/lm.1986911"},{"key":"e_1_2_10_103_1","article-title":"Potential roles of HDAC inhibitors in mitigating ischemia\u2010induced brain damage and facilitating endogenous regeneration and recovery","author":"Fessler EB","journal-title":"Curr Pharm Des"},{"key":"e_1_2_10_104_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.607101"},{"key":"e_1_2_10_105_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.51.5.883"},{"key":"e_1_2_10_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/13.17.6265"},{"key":"e_1_2_10_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.3.291"},{"key":"e_1_2_10_108_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-120611-144851"},{"key":"e_1_2_10_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.09.133"},{"key":"e_1_2_10_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.22409"},{"key":"e_1_2_10_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.10.005"},{"key":"e_1_2_10_112_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds247"},{"key":"e_1_2_10_113_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073811415853"},{"key":"e_1_2_10_114_1","first-page":"141","article-title":"Transcranial magnetic stimulation after conditioning stimulation in two adrenomyeloneuropathy patients: delayed but facilitated motor\u2010evoked potentials","volume":"21","author":"Lai KL","year":"2006","journal-title":"Funct Neurol"},{"key":"e_1_2_10_115_1","first-page":"26","article-title":"Transcranial magnetic stimulation provides means to assess cortical plasticity and excitability in humans with fragile x syndrome and autism spectrum disorder","volume":"2","author":"Oberman L","year":"2010","journal-title":"Front Synaptic Neurosci"},{"key":"e_1_2_10_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24958"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.24002","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.24002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T23:57:10Z","timestamp":1696636630000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.24002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1002\/ana.24002"],"URL":"https:\/\/doi.org\/10.1002\/ana.24002","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}